Mitogen-activated cascades are also critical, where inhibition of mitogen-activated protein kinase (MAPK) and the phosphatidylinositide 3-kinase/Akt/mammalian target of rapamycin PI3K/Akt/mTOR pathways have been shown to inhibit tumour growth [2]. The gene discussed is AKT1; the disease is neoplasm.